Drugmaker Eli Lilly Eliminates 2012 Pay Raises In Cost-Cutting Move
Anyone employed in the pharmaceutical industry knows it's been a tough few years for large drug companies. With few new blockbuster drugs coming down the pipeline and patents expiring on the current crop of profitable ones, many well-known drugmakers have taken strong medicine to cut expenses, including merging ...
Continue Reading »
